Barostim Therapy Global Launch


CVRx, a US-based medical devices company, named HEALTH as their leading global agency partner for the launch of one of the most innovative, implantable technology to treat rHTN and Heart Failure. This device, Barostim neo, or Barostim Therapy, is on the FDA’s “Fast-Track”, and is expected to revolutionise patient care – around the world.  HEALTH worked with the Barostim Therapy marketing team to create a unique concept for HCPs and patients, build a comprehensive 360° campaign, and worked with strategic production partners, Connected Pictures, to film over 25 HCP and Patients testimonials around the world.